Are Platinum Drugs Ineffective for Triple-Negative Breast Cancer With Residual Invasive Disease After Neoadjuvant Chemotherapy? Reply

被引：0

作者：

Mayer, Ingrid A. ^{[1
]}

Zhao, Fengmin ^{[2
]}

Arteaga, Carlos L. ^{[3
]}

Symmans, William F. ^{[4
]}

Park, Ben H. ^{[1
]}

Burnette, Brian L. ^{[5
]}

Tevaarwerk, Amye J. ^{[6
]}

Garcia, Sofia F. ^{[7
]}

Smith, Karen L. ^{[8
]}

Makower, Della F. ^{[9
]}

Block, Margaret ^{[10
]}

Morley, Kimberly A. ^{[11
]}

Jani, Chirag R. ^{[12
]}

Mescher, Craig ^{[13
]}

Dewani, Shabana J. ^{[14
]}

Tawfik, Bernard ^{[15
]}

Flaum, Lisa E. ^{[7
]}

Mayer, Erica L. ^{[16
]}

Sikov, William M. ^{[17
]}

Rodler, Eve T. ^{[18
]}

Wagner, Lynne I. ^{[19
]}

DeMichele, Angela M. ^{[20
]}

Sparano, Joseph A. ^{[9
]}

Wolff, Antonio C. ^{[8
]}

Miller, Kathy D. ^{[21
]}

机构：

[1] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA

[2] Dana Farber Canc Inst, ECOG ACRIN Biostat Ctr, Boston, MA 02115 USA

[3] UT Southwestern Simmons Canc Ctr, Dallas, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[5] Canc Res Wisconsin & Northern Michigan CROWN NCOR, Green Bay, WI USA

[6] Univ Wisconsin Carbone Canc Ctr, Madison, WI USA

[7] Northwestern Univ, Evanston, IL USA

[8] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD USA

[9] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA

[10] Alegent Hlth Bergan Mercy Med Ctr, Omaha, NE USA

[11] St Joseph Mercy Hosp, Ann Arbor, MI 48104 USA

[12] Phoebe Putney Mem Hosp, Albany, GA USA

[13] Metro Minnesota Community Oncol Res Consortium, St Louis Pk, MN USA

[14] Columbus Oncol & Hematol Associates Inc, Columbus, OH USA

[15] Univ New Mexico Canc Ctr, Albuquerque, NM USA

[16] Dana Farber Canc Inst, Boston, MA 02115 USA

[17] Women & Infants Hosp Rhode Isl, Providence, RI 02908 USA

[18] Univ Calif Davis, Davis, CA 95616 USA

[19] Wake Forest Univ Hlth Sci, Winston Salem, NC USA

[20] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[21] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN 46204 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 31期

基金：

美国国家卫生研究院;

关键词：

CAPECITABINE;

D O I：

10.1200/JCO.21.01905

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3522 / +

页数：3

共 50 条

[31] Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy
Pinard, Clemence
Debled, Marc
Ben Rejeb, Houda
Velasco, Valerie
Tunon de Lara, Christine
Hoppe, Stephanie
Richard, Elodie
Brouste, Veronique
Bonnefoi, Herve
MacGrogan, Gaetan
BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (01) : 11 - 23
[32] Comment on "Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer" Reply
Ryu, Han Suk
JOURNAL OF BREAST CANCER, 2017, 20 (01) : 114 - 115
[33] Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
Balko, Justin M.
Giltnane, Jennifer M.
Wang, Kai
Schwarz, Luis J.
Young, Christian D.
Cook, Rebecca S.
Owens, Phillip
Sanders, Melinda E.
Kuba, Maria G.
Sanchez, Violeta
Kurupi, Richard
Moore, Preston D.
Pinto, Joseph A.
Doimi, Franco D.
Gomez, Henry
Horiuchi, Dai
Goga, Andrei
Lehmann, Brian D.
Bauer, Joshua A.
Pietenpol, Jennifer A.
Ross, Jeffrey S.
Palmer, Gary A.
Yelensky, Roman
Cronin, Maureen
Miller, Vincent A.
Stephens, Phillip J.
Arteaga, Carlos L.
CANCER DISCOVERY, 2014, 4 (02) : 232 - 245
[34] Efficacy of capecitabine in chemoresistant PDX established from triple-negative breast cancers with residual disease after neoadjuvant chemotherapy
Marangoni, Elisabetta
Laurent, Cecile
Coussy, Florence
El Botty, Rania
de Plater, Ludmilla
Assayag, Franck
Vacher, Sophie
Bieche, Ivan
Reyal, Fabien
CANCER RESEARCH, 2017, 77
[35] Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy
Clémence Pinard
Marc Debled
Houda Ben Rejeb
Valérie Velasco
Christine Tunon de Lara
Stéphanie Hoppe
Elodie Richard
Véronique Brouste
Hervé Bonnefoi
Gaëtan MacGrogan
Breast Cancer Research and Treatment, 2020, 179 : 11 - 23
[36] Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
da Silva, Jesse Lopes
de Albuquerque, Lucas Zanetti
Rodrigues, Fabiana Resende
de Mesquita, Guilherme Gomes
Fernandes, Priscila Valverde
Thuler, Luiz Claudio Santos
de Melo, Andreia Cristina
FRONTIERS IN ONCOLOGY, 2021, 11
[37] Oncological outcomes in patients with residual triple-negative breast cancer after preoperative chemotherapy
Park, Hyunki
Kim, Haeyoung
Park, Won
Cho, Won Kyung
Kim, Nalee
Kim, Tae Gyu
Im, Young-Hyuck
Ahn, Jin Seok
Park, Yeon Hee
Kim, Ji-Yeon
Nam, Seok Jin
Kim, Seok Won
Lee, Jeong Eon
Yu, Jonghan
Chae, Byung Joo
Lee, Sei Kyung
Ryu, Jai-Min
RADIATION ONCOLOGY JOURNAL, 2024, 42 (03): : 210 - 217
[38] Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the die has not been cast
Tomasik, B.
Bienkowski, M.
Jassem, J.
ANNALS OF ONCOLOGY, 2022, 33 (06) : 658 - 659
[39] Pathological Complete Response with Platinum Containing Neoadjuvant Chemotherapy in Triple-negative Breast Cancer: An Interventional Study
Jose, Binila mary
Kumar, V. R. Ajith
Meloot, Suma Susan
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2024, 18 (04) : XC1 - XC4
[40] Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
Tian, Hao
Ma, Dandan
Tan, Xuanni
Yan, Wenting
Wu, Xiujuan
He, Cheng
Zhong, Ling
Zhang, Yan
Yu, Bingjie
Zhang, Yi
Qi, Xiaowei
FRONTIERS IN PHARMACOLOGY, 2021, 12

← 1 2 3 4 5 →